| Darwin Robert Fisher, PT | |
|
200 Commodore St, Pratt, KS 67124-2903 | |
| (620) 450-1891 | |
| (620) 450-1895 |
| Full Name | Darwin Robert Fisher |
|---|---|
| Gender | Male |
| Speciality | Physical Therapist |
| Location | 200 Commodore St, Pratt, Kansas |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1801230081 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 225100000X | Physical Therapist | 11-03047 (Kansas) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Darwin Robert Fisher, PT 200 Commodore St, Pratt, KS 67124-2903 Ph: (620) 450-1891 | Darwin Robert Fisher, PT 200 Commodore St, Pratt, KS 67124-2903 Ph: (620) 450-1891 |
News Archive
"Health insurer shares rose on Tuesday, while hospital stocks fell as investors anticipated a Republican victory in the special Massachusetts election for a new U.S. senator that would throw healthcare reform into uncertainty," Reuters reports. "The Street prefers a simple narrative," said Les Funtleyder, a health care analyst with Miller Tabak. "The narrative is Coakley in Massachusetts is in trouble and therefore the healthcare reform bill is also in trouble" (Krauskopf, 1/19).
A genetic tool with the potential to identify which trauma and burn patients are most likely to become seriously ill has worked consistently in a wide range of experimental clinical settings - an important hurdle to overcome before the method is routinely used in emergency rooms and intensive care units.
Working with human breast cancer cells and mice, scientists at The Johns Hopkins University say new experiments explain how certain cancer stem cells thrive in low oxygen conditions. Proliferation of such cells, which tend to resist chemotherapy and help tumors spread, are considered a major roadblock to successful cancer treatment.
Teva Pharmaceutical Industries Ltd. today announced results from a Phase III study of QNAZE (beclomethasone dipropionate [BDP]) HFA, a nasal aerosol corticosteroid in development for the treatment of seasonal allergic rhinitis (SAR), that demonstrated significantly greater symptom relief compared with placebo.
In a "look-back" analysis of data stored on 130 patients with pancreatic cysts, scientists at Johns Hopkins have used gene-based tests and a fixed set of clinical criteria to more accurately distinguish precancerous cysts from those less likely to do harm. The findings may eventually help some patients in real time safely avoid surgery to remove harmless cysts.
› Verified 6 days ago
Janet Meyers, P.T. Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 200 Commodore St, Pratt, KS 67124 Phone: 620-450-1896 | |
Shawna L Sterneker, PT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 412 Sandy Ln, South Central Kansas Special Education, Pratt, KS 67124 Phone: 620-388-2890 | |
Mrs. Jessica Lynn Ohler, PT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 412 Sandy Ln, Pratt, KS 67124 Phone: 620-672-7500 | |
Mr. Brandon Paul Forssberg, Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 1219 E 1st St Ste H, Pratt, KS 67124 Phone: 620-388-6277 |